ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Flow Crossmatching for Renal Transplantation in the Virtual Crossmatch Era: Fifty Shades of Grey

R. Cirocco, J. Mendiolina, L. Biondi, M. Moritz

HLA Laboratory and the Transplant Center, Lehigh Valley Health Network, Allentown, PA

Meeting: 2013 American Transplant Congress

Abstract number: D1523

Related Abstracts
  • Positive Flow Crossmatches in Renal Patients without “Detectable” Anti-Donor HLA Antibodies; Maximizing Renal Transplant Rate by Decreasing False Positive Crossmatches
  • Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?

Every transplant team wants a definitive answer for the compatibility of a potential recipient with a specific donor. The Mean Equivalent Standard Fluorescence is a level of fluorescence (MESF) that a flow cytometer measures based on the amount of bound IgG antibody on the donor cell. The cutoff MESF determination (positive = black/ negative=white) is developed for each lab based on their program’s priorities. The reality is there are many shades of grey using one predetermined cut off for T and B cells. Our program uses 1500 MESF for T cells and 2500 MESF for B cells. The question is; would a crossmatch resulting in 2100 for T cells and 3100 for B cells be contraindicative of compatibility? We have studied 131 crossmatches from sensitized potential renal transplant recipients and deceased donors. We use a current and historic (<six months) patient sera for T and B cell flow crossmatches. There were 22 positive crossmatches studied out of 131 performed from 7-1-2011 to 6-30-2012. All of the potential renal transplant recipients demonstrated anti-HLA antibodies (N=131). None had demonstrable anti-HLA antibodies to the donor antigens at the time of crossmatch. We use pronase treated cells in a T and B cell flow crossmatch procedure with Mean Equivalent Standard Fluorescence (MESF) as a read out. Several crossmatches (n=13), (59 %) had IgM interference that was reduced with Dithithreatol (DTT). The untreated sera were positive without DTT treatment and became negative after DTT treatment for both T and B cells. Flu vaccination has been shown to increase anti-HLA antibody activity and may result in a B cell non-specific activation or reactivation. In conclusion: The reduction of IgM in potential recipient sera with DTT, in our laboratory, has allowed a greater number of sensitized patients to be transplanted. 2) An auto crossmatch (donor cells and donor sera) is employed to determine background fluorescence i.e. autoantibody status, and 3) black= positive or white= negative in some deceased donor crossmatches is difficult to determine. Each case’s crossmatch result close or ∼500 MESF above the cutoff (grey area) must be evaluated with the patient necessity for that transplant in mind to determine, if the transplant should be performed.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Cirocco R, Mendiolina J, Biondi L, Moritz M. Flow Crossmatching for Renal Transplantation in the Virtual Crossmatch Era: Fifty Shades of Grey [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/flow-crossmatching-for-renal-transplantation-in-the-virtual-crossmatch-era-fifty-shades-of-grey/. Accessed January 18, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.